In April 2018, CIP VII signed an agreement with CDC Group, the UK government’s development finance institution, to commit up to $300m to pursue secondary opportunities in India-focused private equity funds. The transaction combines CDC’s deep knowledge of the Indian market with Coller Capital’s expertise in complex investments and innovative transaction structures.  In May 2018 the partnership closed on its first transaction, the $98m GP-led secondary investment in a 2008-vintage India-focused fund. The process provided liquidity for the fund’s existing investors.